Published by Coherent Market Insights
Posted on September 20, 2021
5 min readLast updated: February 5, 2026
The biochips market, valued at $7 billion in 2020, is set to grow at a 16.2% CAGR by 2027, driven by disease prevalence and tech advancements.
Coherent Market Insights released a new market study on 2021-2027 Biochips Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Biochips Market Forecast till 2027*.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/1146
Biochip is a miniaturized medical device used in molecular laboratories to carry out several biochemical reactions simultaneously. The device contains millions of biosensors. It is highly efficient and has gained significant popularity in the biochemical field. Biochips are used to detect and quantify molecular complexes. Biochips find applications in areas such as diagnosis of cancer, respiratory diseases, infectious diseases, and for personalized treatment. Thus, with the increasing prevalence of cancer, respiratory diseases, and infectious diseases, the demand for biochips is also increasing with a rapid pace. According to the National Cancer Institute, in 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide.
By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Cancer is one of the leading causes of death worldwide. Thus, increasing prevalence of cancer, respiratory diseases, and infectious diseases is a key factor driving the growth of the biochips market. Moreover, growth of the biochips market is attributed to the increasing adoption of biochips for various research applications, applications in cancer therapies, applications in personalized medicine, and ongoing research and development by market players. Market players are focused on introducing technologically advanced biochips to meet customer needs and demands.
For instance, in February 2018, Micralyne Inc. announced the launch of the MicraFluidics technology, a line of standardized microfluidic process technologies to support high demand from the biomedical and life-sciences industry for rapid design and deployment of integrated microfluidic-based products. Thus, the biochips market is witnessing robust growth due to the increasing research and development activities by market players to enhance technologies in biochips. Furthermore, the pandemic (COVID-19) has increased the focus on the development of diagnostic kits along with the increased use of biochips in pharmaceutical research and development, which is expected to have a positive effect on the biochips market.
The lab-on-a-chip and microarray technology (biochip technology) is expected to play an important role in it. For instance, in February 2020, Veredus Laboratories announced the development of VereCoV detection kit, a portable Lab-on-Chip (biochip) application capable of detecting the Middle-East Respiratory Syndrome Coronavirus (MERS-CoV), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and 2019 Novel Coronavirus (2019-nCoV) in a single test. Furthermore, with the technological advances, the adoption of biochips in proteomics such as microarrays has increased. This in tune is expected to augment the growth of the biochips market over the forecast period.
Biochips Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Randox Laboratories, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Inc., ThermoFisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and PerkinElmer, Inc.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/1146
Reasons to Purchase this Report
• Current and future of global Biochips Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Biochips Market Research Study are:
Request Here Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/1146
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post The biochips market was valued at US$ 7,026.4 million in 2020 and is expected to witness a robust CAGR of 16.2% over the forecast period (2021 – 2027) appeared first on Gatorledger.
The article discusses the growth and future trends of the biochips market, highlighting its expected CAGR and driving factors.
The increasing prevalence of diseases like cancer and advancements in biochip technology are key growth drivers.
The pandemic has increased the focus on biochips for diagnostic kits and pharmaceutical R&D, positively affecting market growth.
Explore more articles in the Research Reports category
